The Filing Desk

OptimizeRx vs Zhongchao

OptimizeRx OPRX · Zhongchao ZCMD · Health Care Technology

OptimizeRx reported revenue of $109 million in fiscal 2025, 9.6 times Zhongchao's $11 million in fiscal 2025. OptimizeRx's revenue grew 18.8% in its latest year, and Zhongchao's fell 28.3%. OptimizeRx had an operating margin of 10.7%, against -54.4% at Zhongchao. Free cash flow was $19 million at OptimizeRx and $1 million at Zhongchao.

Side by side

OptimizeRxZhongchao
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$109M$11M
Revenue growth18.8%−28.3%
Revenue growth a year, last 5 years20.4%−8.7%
Gross margin67.2%45.0%
Operating margin10.7%−54.4%
Net margin4.7%−55.5%
Free cash flow$19M$1M
Free cash flow margin17.1%6.1%
Return on capital6.4%—
Net debt to EBITDA0.2x—
Dividends and buybacks$0M$0M
Change in diluted share count3.9%425.3%
Last close$7.01$0.81
P/E at the last close28.0×—
Insider trades, last 12 monthssold $18,752—
Piotroski F-score8 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
OptimizeRxZhongchao
Operating margin
Percent of revenue
OptimizeRxZhongchao
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OptimizeRxZhongchao

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the OptimizeRx and Zhongchao pages.